Call Options

18 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 15, 2024

BUY
$13.72 - $21.55 $87,808 - $137,920
6,400 Added 31.68%
26,600 $460,000
Q1 2024

May 07, 2024

BUY
$15.95 - $26.8 $47,850 - $80,400
3,000 Added 17.44%
20,200 $323,000
Q4 2023

Feb 14, 2024

BUY
$22.97 - $30.58 $395,084 - $525,976
17,200 New
17,200 $470,000
Q2 2023

Aug 11, 2023

BUY
$25.3 - $39.67 $101,200 - $158,680
4,000 Added 7.25%
59,200 $1.64 Million
Q1 2023

May 16, 2023

SELL
$30.21 - $48.1 $731,082 - $1.16 Million
-24,200 Reduced 30.48%
55,200 $1.84 Million
Q4 2022

Feb 14, 2023

BUY
$22.28 - $38.71 $331,972 - $576,779
14,900 Added 23.1%
79,400 $2.44 Million
Q3 2022

Nov 14, 2022

BUY
$34.2 - $51.69 $1.36 Million - $2.05 Million
39,700 Added 160.08%
64,500 $2.21 Million
Q2 2022

Aug 15, 2022

BUY
$23.14 - $49.68 $423,462 - $909,144
18,300 Added 281.54%
24,800 $860,000
Q1 2022

May 16, 2022

SELL
$27.77 - $64.4 $36,101 - $83,720
-1,300 Reduced 16.67%
6,500 $286,000
Q4 2021

Feb 14, 2022

SELL
$54.9 - $105.21 $362,340 - $694,386
-6,600 Reduced 45.83%
7,800 $490,000
Q3 2021

Nov 15, 2021

SELL
$105.0 - $178.37 $31,500 - $53,511
-300 Reduced 2.04%
14,400 $1.52 Million
Q2 2021

Aug 11, 2021

SELL
$125.11 - $180.0 $4.37 Million - $6.28 Million
-34,900 Reduced 70.36%
14,700 $2.6 Million
Q1 2021

May 17, 2021

BUY
$126.27 - $191.71 $2.84 Million - $4.31 Million
22,500 Added 83.03%
49,600 $6.62 Million
Q4 2020

Feb 16, 2021

SELL
$81.94 - $135.34 $237,626 - $392,486
-2,900 Reduced 9.67%
27,100 $3.67 Million
Q3 2020

Nov 16, 2020

SELL
$73.3 - $89.48 $2.62 Million - $3.2 Million
-35,800 Reduced 54.41%
30,000 $2.5 Million
Q2 2020

Aug 14, 2020

BUY
$48.82 - $82.53 $2.94 Million - $4.97 Million
60,200 Added 1075.0%
65,800 $5.4 Million
Q4 2019

Feb 14, 2020

SELL
$29.79 - $43.06 $306,837 - $443,518
-10,300 Reduced 64.78%
5,600 $233,000
Q1 2019

May 15, 2019

BUY
$21.71 - $31.54 $345,189 - $501,486
15,900 New
15,900 $469,000

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $3.02B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.